Genmab — Oktober 2020

[Solsen]

Cami still looks interesting and now in solid cancer. Wonder what Genmab will do ?

[E_L]

Yes, i am also really curious. The good thing is that Genmab can choose from strength. If they choose not to pursue it, it will not be such a big deal, as they have plenty of other stuff in their pipeline, probably more than they can handle at the moment. So we know that if they do choose to pursue it, we can be reasonably optimistic it can be successfull

[Bulder]

when was the deadline?

[E_L]

"Our collaboration and license agreement with Genmab may require a divestment of Cami, in which Genmab has a 25% interest. On June 24, 2020, we and Genmab agreed to enter into a period of good faith negotiations regarding the key financial terms of our license agreement."

[E_L]

that is all I know. I assume they are still talking

[Solsen]

ADC just raised +$200 mln. Perhaps some of them will go to Genmab

[Bulder]

What are the posibilities? Buying another 25% or selling the 25%?

[troldmanden]

Aftalen skal i hvert fald laves signifikant om hvis Genmab skal smide flere penge efter stoffet. Jeg hælder til Genmab smider de 25%. Mod et lille upfront beløb og så måske 10-25% af ADC fremtidige potentielle royalties. Der skal alligevel en big pharma med ind over for at marekdesføre

[Solsen]

I belive it would be worth trying to make a 50/50 collaboration with ADC. The abstract from solid cancers are very exciting in my view.

[E_L]

well , 50/50 seems to be Jan's favourite number, so who knows And I can't really remember him mentioning the number 0

[SEACOP]

Genmab Announces Data to be Presented at SITC 35th Anniversary Annual Meeting.

[SEACOP]

https://ir.genmab.com/news-releases/news-release-details/genmab-announces-data-be-presented-sitc-35th-anniversary-annual

[transalp]

Go morgen..

[Helge_LarsenPI-redaktør]

Genmab
@Genmab

We’re excited to share updates from Genmab’s pipeline at the virtual #SITC2020, including first-in-human data on a bispecific antibody in joint development with https://ir.genmab.com/news-releases/

[Sukkeralf]

Lad os håbe Novartis begynder at tage markedsandele med Kesimpta, for Ocrevus kører bare derudaf: Roche Q3 sales for Ocrevus: CHF 1.2 billion, up 37%

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[Sukkeralf]

Ocrevus begynder at ligne et 5 milliard dollar drug - bare GSK i sin tid havde sat mere fart over feltet

[Helge_LarsenPI-redaktør]

Tak Sukker. Det er imponerende.

[E_L]

It appears we had a real scoop here yesterday with those SITC abstracts... I was already surprised they were hours early, and even more surprised we could see the content... it seems to have been a mistake lol

[Sukkeralf]

I was also wondering about that because it should have been at late last night at kl 23 and only titles